The AML Hub is an open-access online resource dedicated to providing healthcare professionals with balanced, credible, and up-to-date medical education on acute myeloid leukemia (AML). Our aim is to enhance knowledge in AML through the multichannel dissemination of global advances related to its classification, diagnosis, treatment, and management.
The AML Hub shares new data, evidence-based articles, therapy approvals, expert opinions, and international congress coverage to treatment teams and researchers around the world.
The AML Hub is an independent medical education platform, sponsored by pharmaceutical companies; a full list of our supporters can be found on our website aml-hub.com. The funders are allowed no direct influence on our content.
